{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:38:30Z","timestamp":1793709510808,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004681","name":"HEC Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacl.2026.07.023","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:41:55Z","timestamp":1784562115000},"page":"2020-2027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and clinical characteristics of probable familial chylomicronaemia syndrome at a tertiary care center in Pakistan: Insights from a hospital-based screening study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3727-338X","authenticated-orcid":false,"given":"Quratul","family":"Ain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim-ul","family":"Huda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeeha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amjad","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoraiz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-8107","authenticated-orcid":false,"given":"Jaka","family":"Sikonja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Iqbal","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-2469","authenticated-orcid":false,"given":"Muhammad","family":"Ajmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9399-6078","authenticated-orcid":false,"given":"Fouzia","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5246-9869","authenticated-orcid":false,"given":"Urh","family":"Groselj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2026.07.023_bib1","article-title":"Hypertriglyceridemia\u2014causes, significance, and approaches to therapy","volume":"11","author":"Santos-Baez","year":"2020","journal-title":"Front\u00a0Endocrinol\u00a0(Lausanne)"},{"key":"10.1016\/j.jacl.2026.07.023_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.jacl.2026.07.023_bib3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00325481.2016.1243005","article-title":"Hypertriglyceridemia: the importance of identifying patients at risk","volume":"128","author":"Kushner","year":"2016","journal-title":"Postgrad\u00a0Med"},{"key":"10.1016\/j.jacl.2026.07.023_bib4","series-title":"Endotext","article-title":"Hypertriglyceridemia: pathophysiology, role of genetics, consequences, and treatment","author":"Subramanian","year":"2024"},{"key":"10.1016\/j.jacl.2026.07.023_bib5","first-page":"1132","article-title":"Hypertriglyceridemia-associated pancreatitis: new concepts and potential mechanisms","volume":"69","author":"Hansen","year":"2023","journal-title":"Clin\u00a0Chem"},{"key":"10.1016\/j.jacl.2026.07.023_bib6","first-page":"56","article-title":"Familial chylomicronemia and multifactorial chylomicronemia","volume":"33","author":"Mu\u00f1iz-Grijalvo","year":"2021","journal-title":"Clin\u00a0Investig\u00a0Arterioscler"},{"key":"10.1016\/j.jacl.2026.07.023_bib7","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tcm.2019.03.001","article-title":"Familial chylomicronemia syndrome: a rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis","volume":"30","author":"Chyzhyk","year":"2020","journal-title":"Trends Cardiovasc\u00a0Med"},{"key":"10.1016\/j.jacl.2026.07.023_bib8","article-title":"Genetic and clinical characteristics of patients with lipoprotein lipase deficiency from Slovenia and Pakistan: case series and systematic literature review","volume":"15","author":"Ain","year":"2024","journal-title":"Front\u00a0Endocrinol\u00a0(Lausanne)"},{"key":"10.1016\/j.jacl.2026.07.023_bib9","first-page":"920","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.07.023_bib10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia: differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.023_bib11","first-page":"2334","article-title":"Ethnic diversity and distinctive features of familial versus multifactorial chylomicronemia syndrome: insights from the UK FCS National Registry","volume":"44","author":"Bashir","year":"2024","journal-title":"Arterioscler\u00a0Thromb\u00a0Vasc\u00a0Biol"},{"key":"10.1016\/j.jacl.2026.07.023_bib12","first-page":"1","article-title":"Familial chylomicronemia syndrome (FCS): recent data on diagnosis and treatment","volume":"22","author":"Gallo","year":"2020","journal-title":"Curr\u00a0Atheroscler\u00a0Rep"},{"key":"10.1016\/j.jacl.2026.07.023_bib13","first-page":"e21","article-title":"A systematic review of cost-effectiveness analysis of different screening strategies for familial hypercholesterolemia","volume":"18","author":"Meng","year":"2024","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.07.023_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \u201cFCS score","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.023_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117476","article-title":"Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)","volume":"391","author":"Bashir","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2026.07.023_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100589","article-title":"Clinical characterization and mutation spectrum of patients with hypertriglyceridemia in a German outpatient clinic","volume":"65","author":"Bardey","year":"2024","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacl.2026.07.023_bib17","first-page":"83","article-title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","volume":"19","author":"Hegele","year":"2025","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.07.023_bib18","first-page":"451","article-title":"Trends and prevalence of severe hypertriglyceridemia in Pakistan: a 5-year analysis (2019-2023)","volume":"19","author":"Ain","year":"2025","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.07.023_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s00108-017-0234-z","article-title":"[Severe hypertriglyceridemia: Diagnostics and new treatment principles]","volume":"58","author":"Kassner","year":"2017","journal-title":"Internist (Berl)"},{"key":"10.1016\/j.jacl.2026.07.023_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Nishida","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2026.07.023_bib21","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.3390\/jcm11154311","article-title":"Identifying patients with familial chylomicronemia syndrome using FCS score-based data mining methods","volume":"11","author":"N\u00e9meth","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacl.2026.07.023_bib22","first-page":"2276","article-title":"Prevalence of familial chylomicronemia syndrome in a quaternary care center","volume":"27","author":"Pallazola","year":"2020","journal-title":"Eur\u00a0J\u00a0Prev\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2026.07.023_bib23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/children8111078","article-title":"The effect of a fat-restricted diet in four patients with familial chylomicronemia syndrome: a long-term follow-up study","volume":"8","author":"Thajer","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.jacl.2026.07.023_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/PROM.S441583","article-title":"Cross-sectional quantitative evaluation of a novel patient-reported outcome measure in familial chylomicronemia syndrome","author":"Brown","year":"2024","journal-title":"Patient Relat\u00a0Outcome Meas"},{"key":"10.1016\/j.jacl.2026.07.023_bib25","first-page":"47","article-title":"Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene","volume":"24","author":"Kim","year":"2024","journal-title":"BMC Endocr\u00a0Disord"},{"key":"10.1016\/j.jacl.2026.07.023_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12944-022-01768-x","article-title":"Analyses of familial chylomicronemia syndrome in Pereira, Colombia 2010\u20132020: a cross-sectional study","volume":"22","author":"Rodriguez","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2026.07.023_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.002","article-title":"Diagnostic algorithm for familial chylomicronemia syndrome","volume":"23","author":"Stroes","year":"2017","journal-title":"Atheroscler\u00a0Suppl"},{"key":"10.1016\/j.jacl.2026.07.023_bib28","first-page":"80","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.07.023_bib29","first-page":"71","article-title":"The prevalence of probable familial chylomicronemia syndrome in a southern california population","volume":"27","author":"Tripathi","year":"2021","journal-title":"Endocr\u00a0Pract"},{"key":"10.1016\/j.jacl.2026.07.023_bib30","first-page":"723","article-title":"Recognition and management of persistent chylomicronemia: a joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology","volume":"19","author":"Saadatagah","year":"2025","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2026.07.023_bib31","unstructured":"Inbreeding by Country 2025, (n.d.). https:\/\/worldpopulationreview.com\/country-rankings\/inbreeding-by-country (accessed September 12, 2025)."},{"key":"10.1016\/j.jacl.2026.07.023_bib32","doi-asserted-by":"crossref","first-page":"q2181","DOI":"10.1136\/bmj.q2181","article-title":"Young Pakistanis are moving away from cousin marriage owing to the risk of genetic disorders","volume":"387","author":"Sarkar","year":"2024","journal-title":"BMJ"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742600454X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742600454X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:18:11Z","timestamp":1793708291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742600454X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S193328742600454X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.023","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical characteristics of probable familial chylomicronaemia syndrome at a tertiary care center in Pakistan: Insights from a hospital-based screening study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2026.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}